Treviño C L, Boschi J M, Henzl M T
Department of Chemistry, New Mexico State University, Las Cruces 88003.
J Biol Chem. 1991 Jun 15;266(17):11301-8.
Despite striking sequence homology with rat parvalbumin, oncomodulin exhibits much lower affinity for Ca2+ ion. We are attempting to identify the structural basis for this difference by systematically substituting the parvalbumin residue for the oncomodulin residue at points of nonidentity. In this paper, we examine two mutations in the helical segments flanking the CD ion-binding loop. Replacement of Asp-45 in the C helix by lysine, to produce D45K, reduces the dissociation constant for Ca2+ at the CD site from 0.81 to 0.53 microM. Replacement of Lys-69 in the D helix by glycine, to afford K69G, similarly reduces KCa to 0.59 microM. Both mutations perturb the Eu3+ 7Fo----5Do spectral parameters. We also examine the consequences of simultaneous mutations involving positions 57, 59, 60, and 69. Ca(2+)-binding assays and Eu3+ luminescence measurements indicate that there is a conformational interaction between residues 57 and 69 and that this interaction is modulated by residues 59 and 60. When the mutations at positions 57, 59, 60, and 69 are combined, the resulting variant exhibits a KCa value for the CD site of 0.25 microM, reflecting a 3-fold increase in affinity relative to the wild-type protein. Moreover, the pK alpha governing the interconversion of low and high pH forms of the Eu3+ 7Fo----5Do spectrum is increased to 8.1, very close to the value of 8.25 determined previously for rat parvalbumin. In this paper, we also complete our survey of single mutations in the CD loop by examining L58I. Replacement of Leu-58 by isoleucine reduces the affinity of the CD site for Ca2+, raising KCa to 2.2 microM. Finally, we revise our previous estimate of the KCa value for Y57F downward, from 0.80 to 0.64 microM. The earlier result is believed to have been inflated by heterogeneity in the preparation, a consequence of proteolysis.
尽管癌调蛋白与大鼠小清蛋白在序列上有显著的同源性,但它对Ca2+离子的亲和力要低得多。我们正试图通过在不同位点将小清蛋白残基系统地替换为癌调蛋白残基来确定这种差异的结构基础。在本文中,我们研究了CD离子结合环两侧螺旋段中的两个突变。将C螺旋中的天冬氨酸-45替换为赖氨酸,产生D45K,使CD位点处Ca2+的解离常数从0.81微摩尔降至0.53微摩尔。将D螺旋中的赖氨酸-69替换为甘氨酸,得到K69G,同样将KCa降至0.59微摩尔。这两个突变都扰乱了Eu3+的7Fo→5Do光谱参数。我们还研究了涉及位置57、59、60和69的同时突变的后果。Ca(2+)结合试验和Eu3+发光测量表明,残基57和69之间存在构象相互作用,并且这种相互作用受残基59和60的调节。当位置57、59、60和69处的突变组合时,所得变体在CD位点的KCa值为0.25微摩尔,这表明相对于野生型蛋白亲和力增加了3倍。此外,控制Eu3+的7Fo→5Do光谱低pH和高pH形式相互转化的pKα增加到8.1,非常接近先前测定的大鼠小清蛋白的8.25的值。在本文中,我们还通过研究L58I完成了对CD环中单个突变的研究。将亮氨酸-58替换为异亮氨酸会降低CD位点对Ca2+的亲和力,使KCa升高至2.2微摩尔。最后,我们将之前对Y57F的KCa值估计向下修正,从0.80微摩尔降至0.64微摩尔。据信早期结果因制备过程中的异质性(蛋白水解的结果)而被夸大。